,Set,NGenes,Direction,PValue,FDR
1,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,8,Down,2.20172772120533e-08,1.81422364227319e-05
2,WP_POSTCOVID_NEUROINFLAMMATION,12,Down,9.53479858046712e-08,3.92833701515246e-05
3,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,25,Down,2.32070571684941e-07,6.37420503561305e-05
4,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,34,Down,2.99915464255372e-06,0.000617825856366066
5,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,43,Down,6.1644232499344e-06,0.000787355212523266
6,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,13,Down,6.61145465824305e-06,0.000787355212523266
7,WP_PROSTAGLANDIN_SIGNALING,25,Down,6.68869719376561e-06,0.000787355212523266
8,WP_ZINC_HOMEOSTASIS,24,Up,3.41177061855979e-05,0.00351412373711659
9,WP_SPINAL_CORD_INJURY,69,Down,7.96533926296792e-05,0.00729271061409508
10,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,13,Down,9.99777005973565e-05,0.00820203204773331
11,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.000109493146268284,0.00820203204773331
12,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,16,Down,0.000149134658873298,0.0102405799092998
13,WP_CREATINE_PATHWAY,2,Down,0.000174195315335144,0.0110413030643199
14,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,21,Down,0.000202704281883285,0.0119140066103821
15,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,18,Down,0.00021688118829579,0.0119140066103821
16,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,80,Down,0.000232521728572167,0.0119748690214666
17,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,29,Down,0.000362943772393672,0.017592098144258
18,WP_BENZENE_METABOLISM,3,Up,0.000633258832492365,0.0289891821096505
19,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,8,Down,0.000696640482496089,0.0299754340838878
20,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Up,0.000727559079706014,0.0299754340838878
21,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,14,Down,0.000785775051932274,0.0308323163234378
22,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Down,0.0009372174418622,0.0351030532770206
23,WP_OREXIN_RECEPTOR_PATHWAY,120,Down,0.00128206706379563,0.0459314461116348
24,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.00161269881993842,0.0533667458717764
25,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.00161913670727477,0.0533667458717764
26,WP_BURN_WOUND_HEALING,63,Down,0.00184163681633597,0.0583657206408017
27,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.00220507935729898,0.0671155967018973
28,WP_LUNG_PATHOLOGY_OF_COVID19,16,Down,0.00228062707239457,0.0671155967018973
29,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.00243700235191211,0.0692444806198474
30,WP_VITAMIN_B12_METABOLISM,25,Down,0.00287800558307137,0.079049220015027
31,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.00325099469209021,0.0864135363316881
32,WP_IL26_SIGNALING,33,Down,0.00352188272976328,0.0906884802914045
33,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,22,Down,0.00366731916003307,0.0909933874223017
34,WP_NEUROINFLAMMATION,10,Down,0.00386391573217081,0.0909933874223017
35,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.0038650103880832,0.0909933874223017
36,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,36,Down,0.00448074240374148,0.102559215018972
37,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.00500775504592944,0.111524058320158
38,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.00546927982274637,0.118597015103763
39,WP_ERBB_SIGNALING,68,Down,0.0058365340064878,0.123315487726819
40,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,16,Down,0.00631521694135364,0.124315527720657
41,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.00632452802564426,0.124315527720657
42,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,49,Down,0.00633647107314028,0.124315527720657
43,WP_FOLATE_METABOLISM,38,Down,0.00650851841754539,0.124721376187381
44,WP_COPPER_HOMEOSTASIS,41,Up,0.00667111065286792,0.124931708590072
45,WP_NRF2ARE_REGULATION,20,Up,0.00704053322950023,0.128833448350243
46,WP_TLR4_SIGNALING_AND_TOLERANCE,27,Down,0.00719215852440677,0.128833448350243
47,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,2,Down,0.00819120088897623,0.13561120462166
48,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.00823869564036689,0.13561120462166
49,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.00843190081986016,0.13561120462166
50,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.00854811289851226,0.13561120462166
51,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.00854811289851226,0.13561120462166
52,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,31,Down,0.0085579886411727,0.13561120462166
53,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,12,Down,0.00873280155843606,0.135770348757572
54,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.00947681353964907,0.144609154753164
55,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.0108002112014047,0.159949405335463
56,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Down,0.0109191847792224,0.159949405335463
57,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.0110644612914094,0.159949405335463
58,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.0114221327460787,0.162273058323601
59,WP_INSULIN_SIGNALING,131,Down,0.0125224466822277,0.174889763833147
60,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.0130278693081205,0.178482383310102
61,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.0132128948809663,0.178482383310102
62,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.0140884988803841,0.182729636716014
63,WP_GPCRS_OTHER,15,Down,0.0142621832971151,0.182729636716014
64,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.0143005295217226,0.182729636716014
65,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.014816320336048,0.182729636716014
66,WP_ENDOCHONDRAL_OSSIFICATION,28,Up,0.0148578709465691,0.182729636716014
67,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,28,Up,0.0148578709465691,0.182729636716014
68,WP_KETOGENESIS_AND_KETOLYSIS,6,Up,0.0186185981331242,0.220889202539169
69,WP_MAPK_CASCADE,30,Down,0.0191633024392435,0.220889202539169
70,WP_IL1_SIGNALING,53,Down,0.0191722790920496,0.220889202539169
71,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Up,0.0192473292192071,0.220889202539169
72,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Down,0.0195284943531349,0.220889202539169
73,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.0195690677006788,0.220889202539169
74,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.0222653999424875,0.246688823165177
75,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Down,0.0224534729822673,0.246688823165177
76,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Down,0.0230998321505451,0.246838837656187
77,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.0231334519430846,0.246838837656187
78,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.0233658123024061,0.246838837656187
79,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,16,Down,0.02462949938545,0.254009376370119
80,WP_RANKLRANK_SIGNALING,47,Down,0.0246611045019533,0.254009376370119
81,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.0254152313390553,0.258545069424464
82,WP_HYPERTROPHY_MODEL,13,Down,0.0260716842251011,0.260676126172383
83,WP_GALANIN_RECEPTOR_PATHWAY,12,Down,0.026620579771077,0.260676126172383
84,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.0266973586954266,0.260676126172383
85,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Down,0.0269445840777475,0.260676126172383
86,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.0273964777544144,0.260676126172383
87,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.0278203572826118,0.260676126172383
88,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.0281099012545435,0.260676126172383
89,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.0282308269430269,0.260676126172383
90,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Down,0.0284719069848476,0.260676126172383
91,WP_B_CELL_RECEPTOR_SIGNALING,86,Down,0.0291633089119765,0.264072159818337
92,WP_MONOAMINE_TRANSPORT,12,Down,0.0313298256719763,0.279180049026383
93,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.0315093987372009,0.279180049026383
94,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.0330285614397119,0.28145145236198
95,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.0330501330768051,0.28145145236198
96,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.0330881758679783,0.28145145236198
97,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,19,Down,0.0334286695381822,0.28145145236198
98,WP_NRF2_PATHWAY,72,Up,0.0334735950624685,0.28145145236198
99,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.036064338703305,0.299359890784769
100,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Down,0.0363300838331031,0.299359890784769
101,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.037167342869747,0.301107946862945
102,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,47,Down,0.0372730710922577,0.301107946862945
103,WP_PDGF_PATHWAY,36,Down,0.0387023753168407,0.305897773925143
104,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,64,Down,0.0387207314629973,0.305897773925143
105,WP_ASPIRIN_AND_MIRNAS,8,Down,0.0389796920657039,0.305897773925143
106,WP_PROLACTIN_SIGNALING,69,Down,0.0394109536469093,0.306328766234038
107,WP_NAD_METABOLISM,12,Down,0.0400345987954776,0.306328766234038
108,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,32,Down,0.0401498868365001,0.306328766234038
109,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.0407090530966389,0.307745502308536
110,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Up,0.041234202278237,0.30873605186678
111,WP_SPINA_BIFIDA,10,Down,0.0422575036724238,0.30873605186678
112,WP_DOPAMINE_METABOLISM,7,Up,0.0423282468233049,0.30873605186678
113,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.0423574005959536,0.30873605186678
114,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,51,Down,0.042783563859189,0.30873605186678
115,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.0430881625784947,0.30873605186678
116,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.043834718858045,0.311377658095079
117,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.0446356248219156,0.314356879087679
118,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,21,Down,0.0453138326801856,0.316373685701254
119,WP_GASTRIN_SIGNALING,92,Down,0.0456898890757879,0.316373685701254
120,WP_ARYLAMINE_METABOLISM,1,Up,0.0462686249720184,0.317711224807859
121,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,100,Down,0.048124040083669,0.326531780379708
122,WP_TCELL_RECEPTOR_SIGNALING,74,Down,0.0483457247649567,0.326531780379708
123,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Down,0.0492966947132365,0.330247775965096
124,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Down,0.0506439871998153,0.33297807628758
125,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.0508225963910293,0.33297807628758
126,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Down,0.0509165505002853,0.33297807628758
127,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,26,Down,0.0513960184686354,0.333467080457918
128,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.052637139168608,0.338851583397914
129,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.0552140635804109,0.352685181319834
130,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.0577227252291405,0.365873273760091
131,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,36,Down,0.0582274004370425,0.366254793588725
132,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.0615800312418329,0.38440867987326
133,WP_MAPK_SIGNALING,164,Down,0.06245171115358,0.386918872109398
134,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.0649580404806493,0.393952796194112
135,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,85,Down,0.064984835650873,0.393952796194112
136,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.0650213352941738,0.393952796194112
137,WP_TNFALPHA_SIGNALING,84,Down,0.0656700153933552,0.394978778716239
138,WP_LUNG_FIBROSIS,37,Down,0.0670644770169438,0.400442964217113
139,WP_ALLOGRAFT_REJECTION,51,Down,0.0702850838714149,0.409016414164199
140,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,50,Down,0.0707817484480924,0.409016414164199
141,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.0713049928430755,0.409016414164199
142,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,78,Down,0.0714589176940296,0.409016414164199
143,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.0718869555371537,0.409016414164199
144,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.0720850029563826,0.409016414164199
145,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.0727664168660456,0.409016414164199
146,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,44,Down,0.0728586873256992,0.409016414164199
147,WP_JOUBERT_SYNDROME,71,Up,0.0729677340802637,0.409016414164199
148,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.073489111975879,0.409155596406245
149,WP_KININKALLIKREIN_PATHWAY,2,Up,0.074045560657459,0.409486858937894
150,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,83,Down,0.0775412332984466,0.415814073638962
151,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,87,Down,0.07802074862423,0.415814073638962
152,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,37,Up,0.0785204917261311,0.415814073638962
153,WP_IL18_SIGNALING,193,Down,0.0793369968177946,0.415814073638962
154,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.0794985753419912,0.415814073638962
155,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.0795780614682359,0.415814073638962
156,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.0797103889458457,0.415814073638962
157,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.0797472964864649,0.415814073638962
158,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,24,Down,0.0800530449558133,0.415814073638962
159,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,24,Down,0.0805763864334229,0.415814073638962
160,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,26,Down,0.0807405968230994,0.415814073638962
161,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.0825012172474062,0.421313113073713
162,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.083031187774971,0.421313113073713
163,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,14,Down,0.0835894856686333,0.421313113073713
164,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.0838535807573896,0.421313113073713
165,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.0851955784570393,0.425249854874686
166,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Down,0.0860037283347533,0.425249854874686
167,WP_15Q11Q13_COPY_NUMBER_VARIATION,36,Up,0.0865984388003848,0.425249854874686
168,WP_NETRINUNC5B_SIGNALING,35,Down,0.0872672819987078,0.425249854874686
169,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.087636380923673,0.425249854874686
170,WP_ONCOSTATIN_M_SIGNALING,55,Down,0.0877335865639522,0.425249854874686
171,WP_COMPLEMENT_SYSTEM,53,Up,0.0888356046373015,0.428073322930623
172,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,16,Down,0.0905021644343152,0.431149705865267
173,WP_TP53_NETWORK,16,Down,0.090520508634334,0.431149705865267
174,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.0917207355507259,0.431250189504835
175,WP_MACROPHAGE_MARKERS,8,Down,0.0920194658676099,0.431250189504835
176,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.0921116909621977,0.431250189504835
177,WP_REGULATION_OF_ACTIN_CYTOSKELETON,92,Down,0.0931031587335842,0.433095314468529
178,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.0937010683385701,0.433095314468529
179,WP_TGFBETA_RECEPTOR_SIGNALING,34,Down,0.0940825986527508,0.433095314468529
180,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.0954112093258505,0.435955781884265
181,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.0957621317003058,0.435955781884265
182,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,41,Down,0.0973905278660031,0.439921150734542
183,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,62,Down,0.0977009351752684,0.439921150734542
184,WP_CHEMOKINE_SIGNALING,113,Down,0.0997716512287616,0.446803481589672
185,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Down,0.101325349880058,0.449997754196553
186,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.101577162961843,0.449997754196553
187,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Down,0.102677777909412,0.451529556885196
188,WP_TOLLLIKE_RECEPTOR_SIGNALING,81,Down,0.103018879483516,0.451529556885196
189,WP_BLOOD_CLOTTING_CASCADE,5,Up,0.104674686044157,0.454813776833968
190,WP_EGFEGFR_SIGNALING,141,Down,0.104872108735988,0.454813776833968
191,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.108529950539967,0.465817527183741
192,WP_NUCLEAR_RECEPTORS,20,Down,0.108540006334076,0.465817527183741
193,WP_BENZOAPYRENE_METABOLISM,5,Up,0.113066776188733,0.481839239578104
194,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Down,0.113442733589991,0.481839239578104
195,WP_GLUCURONIDATION,7,Up,0.114845832623403,0.483336426043943
196,WP_COMPLEMENT_ACTIVATION,12,Up,0.115147643699794,0.483336426043943
197,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.115554946517787,0.483336426043943
198,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Up,0.119818319591824,0.494792390273758
199,WP_TAR_SYNDROME,45,Down,0.119850471949668,0.494792390273758
200,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Up,0.120615328601236,0.494792390273758
201,WP_KLEEFSTRA_SYNDROME,25,Down,0.120926497679166,0.494792390273758
202,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Down,0.121769191737093,0.494792390273758
203,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.122527847620832,0.494792390273758
204,WP_CHOLESTASIS,9,Up,0.122895526558969,0.494792390273758
205,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.123097621366651,0.494792390273758
206,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,74,Down,0.124818313690559,0.497138736594716
207,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.124888007858139,0.497138736594716
208,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Up,0.126559100322895,0.501368743586855
209,WP_PURINE_METABOLISM,10,Down,0.127993998356908,0.504627055722928
210,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Up,0.129577664094019,0.506534347056962
211,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.129707217510945,0.506534347056962
212,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Down,0.130600638097531,0.507301502367785
213,WP_KIT_RECEPTOR_SIGNALING,52,Down,0.13113497573342,0.507301502367785
214,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Down,0.132664897981321,0.51082185017107
215,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.134156247366905,0.511840265312393
216,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.134856220009555,0.511840265312393
217,WP_FERROPTOSIS,51,Up,0.135397038546721,0.511840265312393
218,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.136072055277523,0.511840265312393
219,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.136320229285739,0.511840265312393
220,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Down,0.136889132454098,0.511840265312393
221,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.137277546885969,0.511840265312393
222,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,61,Down,0.139487122533832,0.514594415058547
223,WP_SELENIUM_MICRONUTRIENT_NETWORK,52,Down,0.139901197612522,0.514594415058547
224,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.140500700018196,0.514594415058547
225,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.140514251684676,0.514594415058547
226,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,12,Up,0.142442968794655,0.519349585339804
227,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.14520494279956,0.527087545668887
228,WP_TAMOXIFEN_METABOLISM,2,Up,0.147613108527178,0.533478953624537
229,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.149773715516495,0.537856053594018
230,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,175,Down,0.150129723697359,0.537856053594018
231,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,13,Up,0.154201955961732,0.545101239316494
232,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.15514497343559,0.545101239316494
233,WP_SERINE_METABOLISM,5,Down,0.155242762264006,0.545101239316494
234,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.156729835668608,0.545101239316494
235,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.156760999312692,0.545101239316494
236,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.157193076149546,0.545101239316494
237,WP_LEPTIN_SIGNALING,69,Down,0.157321818103039,0.545101239316494
238,WP_PLEURAL_MESOTHELIOMA,259,Down,0.157444289996754,0.545101239316494
239,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.158237352361643,0.545554721112944
240,WP_PHOSPHOINOSITIDES_METABOLISM,38,Down,0.165012950804528,0.566544464428879
241,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.167816489521566,0.572163729595426
242,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.168038376895744,0.572163729595426
243,WP_G13_SIGNALING,29,Down,0.169073081362441,0.573317773838073
244,WP_GPCRS_CLASS_A_RHODOPSINLIKE,47,Down,0.17032958382024,0.57408841833812
245,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.170835915629473,0.57408841833812
246,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.171819292508817,0.57408841833812
247,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.172087183652325,0.57408841833812
248,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.173083984645293,0.575085497369845
249,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,33,Down,0.175544303504223,0.58091769513044
250,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.177307651692171,0.58388606106295
251,WP_SEROTONIN_AND_ANXIETY,7,Down,0.177858496755826,0.58388606106295
252,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Down,0.179562068867623,0.587139463281433
253,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,36,Down,0.180856937490149,0.587752414476808
254,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.181176108346007,0.587752414476808
255,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.18206951736381,0.588334440422665
256,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.183673441180628,0.591050008737746
257,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,41,Down,0.184344480880583,0.591050008737746
258,WP_INTEGRINMEDIATED_CELL_ADHESION,73,Down,0.185099913265953,0.591171816012192
259,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.1860231511542,0.591826550390195
260,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.186977016434936,0.592573313624565
261,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.193911463477896,0.610702496084611
262,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.195146651518703,0.610702496084611
263,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Down,0.195602191485188,0.610702496084611
264,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.195661964764972,0.610702496084611
265,WP_GLIOBLASTOMA_SIGNALING,68,Down,0.1992213267514,0.616287156335346
266,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.20051634685197,0.616287156335346
267,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.200664429851875,0.616287156335346
268,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.20098706661041,0.616287156335346
269,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,140,Down,0.20137340453678,0.616287156335346
270,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,40,Down,0.201938752682698,0.616287156335346
271,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.203662988603555,0.619255729185716
272,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.205153883879385,0.621495589399312
273,WP_GLUTATHIONE_METABOLISM,10,Up,0.209019447997356,0.628680575888352
274,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.209051550720156,0.628680575888352
275,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Down,0.210836533864458,0.631742923288412
276,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.212699627055056,0.633520952835288
277,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.212967601863319,0.633520952835288
278,WP_BDNFTRKB_SIGNALING,26,Down,0.214401669187891,0.634850535142874
279,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.215137900784102,0.634850535142874
280,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Down,0.215725910000006,0.634850535142874
281,WP_UROTENSINIIMEDIATED_SIGNALING,50,Down,0.219767701464225,0.643803427123453
282,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,64,Up,0.220330784525259,0.643803427123453
283,WP_ENDOMETRIAL_CANCER,49,Down,0.222502319304592,0.647851275996408
284,WP_ID_SIGNALING,12,Down,0.228963376446329,0.664316275323151
285,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.232247854135656,0.66925357982266
286,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.232289470666603,0.66925357982266
287,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.236210577434274,0.67315157331867
288,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,15,Down,0.236283608406543,0.67315157331867
289,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.237907752485754,0.67315157331867
290,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Down,0.238236787653061,0.67315157331867
291,WP_NEURAL_CREST_DIFFERENTIATION,40,Down,0.238588868510539,0.67315157331867
292,WP_TRANSLATION_FACTORS,49,Down,0.238639661965391,0.67315157331867
293,WP_BLADDER_CANCER,30,Down,0.239360935658216,0.67315157331867
294,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.240405806649021,0.673790424077528
295,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.242424720723591,0.675797281727061
296,WP_GASTRIC_CANCER_NETWORK_2,26,Down,0.242762130329139,0.675797281727061
297,WP_OVARIAN_INFERTILITY,21,Down,0.244691031167117,0.678873433271732
298,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.247403715209686,0.684008072244232
299,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Down,0.248201958253672,0.684008072244232
300,WP_RETT_SYNDROME,32,Down,0.249636766369646,0.685131945305182
301,WP_OSTEOBLAST_SIGNALING,3,Down,0.251018443481635,0.685131945305182
302,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,48,Down,0.251104183837579,0.685131945305182
303,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,16,Down,0.253817016389022,0.690248255790608
304,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.254823658131911,0.69058565924726
305,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.255617264648561,0.69058565924726
306,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.25982219475676,0.697459229696672
307,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.260869262808649,0.697459229696672
308,WP_PYRIMIDINE_METABOLISM,71,Down,0.261194125265595,0.697459229696672
309,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Up,0.262346216364591,0.697459229696672
310,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Down,0.262393642240253,0.697459229696672
311,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.271199742479809,0.71805436129984
312,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.272541882184312,0.71805436129984
313,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.272992223953524,0.71805436129984
314,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,32,Down,0.274182585082386,0.71805436129984
315,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.274498936661953,0.71805436129984
316,WP_NOTCH_SIGNALING_WP61,49,Down,0.277577851047435,0.720461924820382
317,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Down,0.278080013656391,0.720461924820382
318,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,64,Up,0.279167047551797,0.720461924820382
319,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.279740832072221,0.720461924820382
320,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.279791038765197,0.720461924820382
321,WP_MRNA_PROCESSING,124,Down,0.282232271491641,0.722871016434499
322,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,57,Up,0.282815463721444,0.722871016434499
323,WP_EBOLA_VIRUS_INFECTION_IN_HOST,109,Down,0.284491398544678,0.722871016434499
324,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.284660488041096,0.722871016434499
325,WP_HEPATITIS_B_INFECTION,119,Down,0.285112961579141,0.722871016434499
326,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.288291288040759,0.728214695587298
327,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.289704491102962,0.728214695587298
328,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.289871869117274,0.728214695587298
329,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.294153653807818,0.734727194659994
330,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.294247541550726,0.734727194659994
331,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.296677640694048,0.737999671592574
332,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.29734938224361,0.737999671592574
333,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.302623539024302,0.742726827857342
334,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.303858407109079,0.742726827857342
335,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.304874261261444,0.742726827857342
336,WP_IL7_SIGNALING,23,Up,0.305209792745598,0.742726827857342
337,WP_ADIPOGENESIS,87,Down,0.306035837334366,0.742726827857342
338,WP_PROTEASOME_DEGRADATION,57,Down,0.30644572768005,0.742726827857342
339,WP_IRINOTECAN_PATHWAY,5,Up,0.308090361719058,0.742726827857342
340,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.308831961805169,0.742726827857342
341,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.310621788626854,0.742726827857342
342,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.310912395196376,0.742726827857342
343,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.310912395196376,0.742726827857342
344,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.310918748275208,0.742726827857342
345,WP_ECTODERM_DIFFERENTIATION,78,Up,0.311038946699757,0.742726827857342
346,WP_CYTOSOLIC_DNASENSING_PATHWAY,54,Down,0.311873158299321,0.742726827857342
347,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.316360278376828,0.749260773932448
348,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.316435375398655,0.749260773932448
349,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.317965413224463,0.750726362455466
350,WP_MELANOMA,55,Down,0.319212391055093,0.751439199398158
351,WP_GLYCOLYSIS_IN_SENESCENCE,11,Down,0.320091212364992,0.751439199398158
352,WP_NRXN1_DELETION_SYNDROME,2,Down,0.321989160527923,0.753747353054001
353,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.327861876503275,0.760366664920741
354,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.329241351788035,0.760366664920741
355,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.330053330468731,0.760366664920741
356,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.331120695802504,0.760366664920741
357,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.331326426632509,0.760366664920741
358,WP_HEDGEHOG_SIGNALING_WP4249,24,Down,0.331796905172871,0.760366664920741
359,WP_AUTOPHAGY,27,Down,0.331978780500497,0.760366664920741
360,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.332199028363431,0.760366664920741
361,WP_APOPTOSIS,72,Down,0.334400521193583,0.763029401709271
362,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.335214373081015,0.763029401709271
363,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.337294849873984,0.7645938910251
364,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Down,0.338663992509773,0.7645938910251
365,WP_SMALL_CELL_LUNG_CANCER,71,Down,0.33948283719598,0.7645938910251
366,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.339613305965032,0.7645938910251
367,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,50,Down,0.340644281330111,0.764825307400577
368,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.342562295591539,0.76704166186801
369,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.344216628679966,0.76706719263475
370,WP_SYNAPTIC_VESICLE_PATHWAY,23,Down,0.345831692662346,0.76706719263475
371,WP_TRANSSULFURATION_PATHWAY,8,Down,0.348200652083376,0.76706719263475
372,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.349354158725797,0.76706719263475
373,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,58,Down,0.351533043928864,0.76706719263475
374,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Up,0.351650835824335,0.76706719263475
375,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.354296593593626,0.76706719263475
376,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.35438533522982,0.76706719263475
377,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Down,0.354500169808383,0.76706719263475
378,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.355303875370607,0.76706719263475
379,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.355747709241987,0.76706719263475
380,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.357527978853064,0.76706719263475
381,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Down,0.3578754994575,0.76706719263475
382,WP_HUNGER_AND_SATIETY,2,Up,0.357887416577935,0.76706719263475
383,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.358001089789405,0.76706719263475
384,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,71,Down,0.359103305101457,0.76706719263475
385,WP_IL9_SIGNALING,15,Up,0.359934673405757,0.76706719263475
386,WP_PPAR_SIGNALING,39,Up,0.360712107199303,0.76706719263475
387,WP_METHYLATION_PATHWAYS,5,Up,0.360790548042584,0.76706719263475
388,WP_OSTEOCLAST_SIGNALING,9,Up,0.36232757505684,0.76706719263475
389,WP_VEGFAVEGFR2_SIGNALING,342,Down,0.363157560255108,0.76706719263475
390,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.365915813284938,0.76706719263475
391,WP_IL4_SIGNALING,50,Down,0.365922364369695,0.76706719263475
392,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,74,Up,0.367666455612047,0.76706719263475
393,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.367879048388896,0.76706719263475
394,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,15,Down,0.36868407747298,0.76706719263475
395,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.369587369685937,0.76706719263475
396,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.370026675785588,0.76706719263475
397,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.370271791235239,0.76706719263475
398,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Down,0.37214078105351,0.76706719263475
399,WP_TRYPTOPHAN_METABOLISM,19,Up,0.372557530342964,0.76706719263475
400,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.373552722231303,0.76706719263475
401,WP_P38_MAPK_SIGNALING,31,Down,0.374248483384339,0.76706719263475
402,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Up,0.374541172660764,0.76706719263475
403,WP_ATM_SIGNALING,34,Down,0.375155435232772,0.76706719263475
404,WP_ENDODERM_DIFFERENTIATION,82,Down,0.376490494149008,0.767891502917779
405,WP_HIPPO_SIGNALING_REGULATION,45,Down,0.383731026544043,0.780726829314301
406,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.385979030701678,0.781411419563878
407,WP_IRON_METABOLISM_IN_PLACENTA,10,Down,0.386370091995113,0.781411419563878
408,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Down,0.388046449318831,0.781411419563878
409,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,48,Down,0.389230365206169,0.781411419563878
410,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.38973418294497,0.781411419563878
411,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.390616501056447,0.781411419563878
412,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.390705709781939,0.781411419563878
413,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.392828885102634,0.783353113309685
414,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,10,Down,0.393577899162876,0.783353113309685
415,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.395705150121068,0.785689261927133
416,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Up,0.397311282070755,0.786286208092021
417,WP_AXON_GUIDANCE,37,Down,0.397914258221326,0.786286208092021
418,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Up,0.402762385498211,0.793962214474942
419,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.406786100201818,0.799980302067537
420,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.40776117648883,0.799988593873324
421,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Up,0.410926426279566,0.80428355167307
422,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.412110670968242,0.804690030516188
423,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.41539913734474,0.809193591423323
424,WP_PANCREATIC_CANCER_SUBTYPES,6,Up,0.421905862254188,0.819220584768603
425,WP_ENERGY_METABOLISM,41,Down,0.422534888988661,0.819220584768603
426,WP_SILDENAFIL_TREATMENT,11,Down,0.426164018731023,0.82267200273265
427,WP_GPR40_PATHWAY,8,Down,0.426402422644851,0.82267200273265
428,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,41,Down,0.427498716718337,0.82267200273265
429,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.428751280443229,0.82267200273265
430,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.429306991717281,0.82267200273265
431,WP_ACE_INHIBITOR_PATHWAY,5,Down,0.430844235416332,0.823702204137024
432,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,64,Down,0.433168800047304,0.825826241323947
433,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.434875674495268,0.825826241323947
434,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.436207576633404,0.825826241323947
435,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.437451281846348,0.825826241323947
436,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Down,0.437551156670968,0.825826241323947
437,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.437968528469132,0.825826241323947
438,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.439811672589682,0.826806050035443
439,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.44049497083199,0.826806050035443
440,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,3,Down,0.44405241027329,0.83158905923907
441,WP_THERMOGENESIS,74,Down,0.449738066518488,0.840326908869011
442,WP_ONECARBON_METABOLISM,22,Down,0.451368916435578,0.840979791855637
443,WP_AMINO_ACID_METABOLISM,60,Up,0.452128698776756,0.840979791855637
444,WP_GLYOXYLATE_METABOLISM,5,Up,0.455698173882497,0.845710124502652
445,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.457775530752389,0.847656263685322
446,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Down,0.459677805687594,0.849270206023716
447,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,87,Down,0.462398470477553,0.851614325956531
448,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.46346476016597,0.851614325956531
449,WP_CIRCADIAN_RHYTHM_GENES,122,Down,0.464047126643789,0.851614325956531
450,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.467113446972185,0.854942739349531
451,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,12,Down,0.46815619775465,0.854942739349531
452,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,1,Down,0.468973444400471,0.854942739349531
453,WP_VITAMIN_B12_DISORDERS,9,Up,0.472759956969324,0.855134643760702
454,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Up,0.474403253528877,0.855134643760702
455,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.475361949217413,0.855134643760702
456,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.475517481717363,0.855134643760702
457,WP_IL6_SIGNALING,40,Down,0.477514767264175,0.855134643760702
458,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.479108163936089,0.855134643760702
459,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.48035971366818,0.855134643760702
460,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.481054990499937,0.855134643760702
461,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.48166357152363,0.855134643760702
462,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.483768032773259,0.855134643760702
463,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.48378057837832,0.855134643760702
464,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.483989416531845,0.855134643760702
465,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.485106762271214,0.855134643760702
466,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Up,0.485555675294632,0.855134643760702
467,WP_DRAVET_SYNDROME,14,Down,0.488148936747008,0.855134643760702
468,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.489733630995991,0.855134643760702
469,WP_CORI_CYCLE,11,Down,0.490545661343688,0.855134643760702
470,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Up,0.490708736287095,0.855134643760702
471,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.491250890493171,0.855134643760702
472,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.493396975947645,0.855134643760702
473,WP_FATTY_ACID_BETAOXIDATION,29,Up,0.493555052826418,0.855134643760702
474,WP_IRON_METABOLISM_DISORDERS,13,Up,0.493890356927702,0.855134643760702
475,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.494362475388577,0.855134643760702
476,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Down,0.494872708615813,0.855134643760702
477,WP_RAC1PAK1P38MMP2_PATHWAY,51,Down,0.496423127845738,0.855134643760702
478,WP_ATR_SIGNALING,10,Up,0.496521598191976,0.855134643760702
479,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.497098900924,0.855134643760702
480,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.501007609337867,0.859256655329892
481,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Up,0.503048036384417,0.859256655329892
482,WP_EICOSANOID_SYNTHESIS,14,Down,0.504077511976688,0.859256655329892
483,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Down,0.504392804373457,0.859256655329892
484,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.506298789259619,0.859256655329892
485,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.506847859654756,0.859256655329892
486,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Up,0.507398496521745,0.859256655329892
487,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Down,0.507837367895215,0.859256655329892
488,WP_MALE_INFERTILITY,70,Down,0.511117508284501,0.863034481201699
489,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.512180098356878,0.863060124838583
490,WP_ALZHEIMERS_DISEASE,185,Down,0.515526032796087,0.864586163132719
491,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,185,Down,0.515526032796087,0.864586163132719
492,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.51662289583509,0.864586163132719
493,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.518316621381073,0.864586163132719
494,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,0.518369207417827,0.864586163132719
495,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.520677623558875,0.864586163132719
496,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.523198858775938,0.864586163132719
497,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.523393129705563,0.864586163132719
498,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.52372870233087,0.864586163132719
499,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.52500955724826,0.864586163132719
500,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,58,Up,0.525319735423947,0.864586163132719
501,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Down,0.525676781225112,0.864586163132719
502,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,92,Down,0.53121802610369,0.869403962427556
503,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.531543899623406,0.869403962427556
504,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.5318515512162,0.869403962427556
505,WP_BARDETBIEDL_SYNDROME,65,Up,0.533719304906537,0.869403962427556
506,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.533881559451873,0.869403962427556
507,WP_FOXP3_IN_COVID19,10,Down,0.535633661673364,0.870536759800497
508,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.539974912163471,0.874572124204517
509,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Up,0.540719234304592,0.874572124204517
510,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.541300707942116,0.874572124204517
511,WP_NPHP1_DELETION_SYNDROME,10,Down,0.543580142057958,0.87586240390484
512,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.545288122819397,0.87586240390484
513,WP_HEME_BIOSYNTHESIS,8,Down,0.545288122819397,0.87586240390484
514,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,60,Down,0.547299389451344,0.875898609680401
515,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.548519153956957,0.875898609680401
516,WP_ESTROGEN_SIGNALING,21,Down,0.549146734519818,0.875898609680401
517,WP_KALLMANN_SYNDROME,11,Up,0.549562598549475,0.875898609680401
518,WP_MATRIX_METALLOPROTEINASES,9,Up,0.551172443262663,0.876174860918269
519,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,12,Up,0.551862564097793,0.876174860918269
520,WP_METABOLIC_EPILEPTIC_DISORDERS,58,Down,0.553732148295048,0.877452481144461
521,WP_NEPHROTIC_SYNDROME,27,Up,0.555624212775623,0.878760751107704
522,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.559370856905452,0.882334882347727
523,WP_MESODERMAL_COMMITMENT_PATHWAY,76,Down,0.560025659548375,0.882334882347727
524,WP_CHOLESTEROL_METABOLISM,53,Up,0.562291758960981,0.884214521724901
525,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.563425252472088,0.884309348641906
526,WP_CILIOPATHIES,128,Up,0.56713246491623,0.88638579017417
527,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.567726458300514,0.88638579017417
528,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.568876486990429,0.88638579017417
529,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.569051071604534,0.88638579017417
530,WP_AGERAGE_PATHWAY,55,Down,0.571276778791046,0.888173708912872
531,WP_MEASLES_VIRUS_INFECTION,102,Up,0.578404359898441,0.896784515571556
532,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.5789919445195,0.896784515571556
533,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.581029926706987,0.897052569979518
534,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Up,0.581781785548081,0.897052569979518
535,WP_RETINOBLASTOMA_GENE_IN_CANCER,72,Down,0.582430976867769,0.897052569979518
536,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Down,0.583982836590727,0.897764659236491
537,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Down,0.586513628392548,0.898366348117732
538,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.587599207390852,0.898366348117732
539,WP_ULCERATIVE_COLITIS_SIGNALING,12,Down,0.587644977712934,0.898366348117732
540,WP_CANCER_PATHWAYS,310,Up,0.599137475321372,0.91194672996833
541,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.599616505055923,0.91194672996833
542,WP_APOPTOSIS_MODULATION_AND_SIGNALING,79,Down,0.600143491867043,0.91194672996833
543,WP_RETINOL_METABOLISM,6,Up,0.603214165187827,0.91194672996833
544,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,53,Up,0.60388281107486,0.91194672996833
545,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Down,0.604046623610565,0.91194672996833
546,WP_DNA_REPLICATION,36,Up,0.606131494490021,0.91194672996833
547,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.608439072812729,0.91194672996833
548,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.608951920932094,0.91194672996833
549,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.610908226638062,0.91194672996833
550,WP_PREIMPLANTATION_EMBRYO,21,Down,0.611397352327769,0.91194672996833
551,WP_IL3_SIGNALING,46,Down,0.612128049644992,0.91194672996833
552,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Down,0.613226983525045,0.91194672996833
553,WP_NEPHROGENESIS,4,Up,0.614351125312275,0.91194672996833
554,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.615945485467513,0.91194672996833
555,WP_ENDOTHELIN_PATHWAYS,12,Up,0.616357540693788,0.91194672996833
556,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,43,Down,0.617445022559482,0.91194672996833
557,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.618455537201422,0.91194672996833
558,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.619115902381586,0.91194672996833
559,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,0.619748897250921,0.91194672996833
560,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Up,0.620453030189698,0.91194672996833
561,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.620876353776982,0.91194672996833
562,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Up,0.622369276778588,0.912512960970741
563,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.623792225811848,0.912974767440432
564,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Up,0.629042293027064,0.919026328819683
565,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.631728659566919,0.920253186315512
566,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.634158709339039,0.920253186315512
567,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.634981101395217,0.920253186315512
568,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Down,0.635368693335896,0.920253186315512
569,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.638746837350129,0.920253186315512
570,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.639431457731822,0.920253186315512
571,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.640336263241857,0.920253186315512
572,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.640555868640147,0.920253186315512
573,WP_SPHINGOLIPID_PATHWAY,21,Down,0.64177507881117,0.920253186315512
574,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Up,0.645202471285306,0.920253186315512
575,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Up,0.646283834119083,0.920253186315512
576,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.647047570828041,0.920253186315512
577,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.64738222684541,0.920253186315512
578,WP_WNT_SIGNALING_WP363,39,Down,0.648479938050917,0.920253186315512
579,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.649357649027042,0.920253186315512
580,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.649357649027042,0.920253186315512
581,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,9,Down,0.649794674591322,0.920253186315512
582,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.651693614609412,0.920253186315512
583,WP_MIRNA_BIOGENESIS,6,Up,0.651768683372385,0.920253186315512
584,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.652218277679926,0.920253186315512
585,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.657732316094625,0.920497301236835
586,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.658825680527741,0.920497301236835
587,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.659980171987467,0.920497301236835
588,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.660156914364056,0.920497301236835
589,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,57,Up,0.660339633929941,0.920497301236835
590,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Up,0.660960257401121,0.920497301236835
591,WP_16P112_DISTAL_DELETION_SYNDROME,21,Up,0.66224436909462,0.920497301236835
592,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Up,0.664275090485269,0.920497301236835
593,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Up,0.666119381971174,0.920497301236835
594,WP_SLEEP_REGULATION,12,Down,0.666805971366115,0.920497301236835
595,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,18,Up,0.66717484683628,0.920497301236835
596,WP_G1_TO_S_CELL_CYCLE_CONTROL,53,Up,0.66912030576914,0.920497301236835
597,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,74,Down,0.669146737558408,0.920497301236835
598,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Down,0.66966468022981,0.920497301236835
599,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.669943546098656,0.920497301236835
600,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.670265025172453,0.920497301236835
601,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.673207239390464,0.92148375447445
602,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Down,0.673219927419441,0.92148375447445
603,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.676228707906082,0.923610209983502
604,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.679527065751132,0.923610209983502
605,WP_BREAST_CANCER_PATHWAY,88,Down,0.680036419391771,0.923610209983502
606,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.680877806562574,0.923610209983502
607,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.68104932636432,0.923610209983502
608,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.681498795715982,0.923610209983502
609,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.68389959550456,0.925341981438026
610,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.686261885172183,0.926627559336858
611,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.689108325184456,0.926627559336858
612,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Down,0.689149136705999,0.926627559336858
613,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,10,Down,0.689426536586519,0.926627559336858
614,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,36,Up,0.691148939524515,0.926627559336858
615,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.693411656831557,0.926627559336858
616,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Up,0.693960743128833,0.926627559336858
617,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.695612902149123,0.926627559336858
618,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.695960831225687,0.926627559336858
619,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.697151439306738,0.926627559336858
620,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,14,Down,0.698131395588719,0.926627559336858
621,WP_SMALL_LIGAND_GPCRS,7,Up,0.698344313529355,0.926627559336858
622,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.702407818536684,0.930520968608083
623,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.70496837269847,0.931149897220807
624,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.708124681666536,0.931149897220807
625,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.709254755639672,0.931149897220807
626,WP_IDO_METABOLIC_PATHWAY,8,Down,0.709702750511097,0.931149897220807
627,WP_MTHFR_DEFICIENCY,18,Down,0.710207385925346,0.931149897220807
628,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.711622285731297,0.931149897220807
629,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.712859426226524,0.931149897220807
630,WP_DNA_DAMAGE_RESPONSE,59,Down,0.713141098223025,0.931149897220807
631,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.713648547866289,0.931149897220807
632,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.714182930878094,0.931149897220807
633,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.716873480551215,0.933181276420539
634,WP_MONOAMINE_GPCRS,4,Up,0.721511552949373,0.934427921633212
635,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.723516563754409,0.934427921633212
636,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.723705616031185,0.934427921633212
637,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Down,0.723894460340452,0.934427921633212
638,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.724003020707939,0.934427921633212
639,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.72463524505294,0.934427921633212
640,WP_GASTRIC_CANCER_NETWORK_1,18,Up,0.727327787694494,0.936434526656661
641,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,54,Down,0.729296633043011,0.937504564161374
642,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.736490331730604,0.940019767427132
643,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.736490331730604,0.940019767427132
644,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.736543844870713,0.940019767427132
645,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Down,0.737132916555774,0.940019767427132
646,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.738691116289385,0.940019767427132
647,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Up,0.740130063038627,0.940019767427132
648,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.740217901240714,0.940019767427132
649,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Up,0.740379646917729,0.940019767427132
650,WP_IL10_ANTIINFLAMMATORY_SIGNALING,11,Down,0.742525619375628,0.94129401594695
651,WP_FOCAL_ADHESION,121,Down,0.745331380759265,0.941449584599557
652,WP_PDGFRBETA_PATHWAY,27,Up,0.746605315549197,0.941449584599557
653,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.747682724624022,0.941449584599557
654,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.747990559375547,0.941449584599557
655,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,128,Down,0.7513150075914,0.941449584599557
656,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.756620448607797,0.941449584599557
657,WP_13Q1212_COPY_NUMBER_VARIATION,20,Up,0.760567041769308,0.941449584599557
658,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.761318174614238,0.941449584599557
659,WP_NONSMALL_CELL_LUNG_CANCER,60,Down,0.761743926660509,0.941449584599557
660,WP_OPIOID_RECEPTOR_PATHWAYS,26,Down,0.762073478681583,0.941449584599557
661,WP_NUCLEAR_RECEPTORS_METAPATHWAY,179,Down,0.762258838058951,0.941449584599557
662,WP_FRAGILE_X_SYNDROME,85,Down,0.762676052388997,0.941449584599557
663,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,47,Down,0.762995146637704,0.941449584599557
664,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,168,Up,0.764074571999874,0.941449584599557
665,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,130,Down,0.76483843676375,0.941449584599557
666,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.766440689658542,0.941449584599557
667,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.766454177513456,0.941449584599557
668,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.767941870882081,0.941449584599557
669,WP_IL17_SIGNALING,25,Down,0.767945777131054,0.941449584599557
670,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.768392073390935,0.941449584599557
671,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,17,Up,0.769243950357821,0.941449584599557
672,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,68,Up,0.770385894030262,0.941449584599557
673,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Down,0.770478271779945,0.941449584599557
674,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.771776557801464,0.941449584599557
675,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.773061258866544,0.941449584599557
676,WP_NEOVASCULARIZATION_PROCESSES,23,Down,0.773361911346966,0.941449584599557
677,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.773496806764442,0.941449584599557
678,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.775701681144526,0.941583794410918
679,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.775892471365308,0.941583794410918
680,WP_TGFB_SMAD_SIGNALING,7,Up,0.777382904849091,0.942005167052428
681,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,26,Down,0.781171906771534,0.944304667892037
682,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,71,Up,0.781572552794137,0.944304667892037
683,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.783279261576147,0.94498112963213
684,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.786341712485763,0.945342425239735
685,WP_IL19_SIGNALING,20,Up,0.786437045971637,0.945342425239735
686,WP_DISORDERS_IN_KETOLYSIS,4,Up,0.787997497133687,0.945342425239735
687,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,9,Up,0.788167774441381,0.945342425239735
688,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Up,0.793912669081303,0.950848894364817
689,WP_TCELL_ACTIVATION_SARSCOV2,61,Up,0.797773637708642,0.95408632434241
690,WP_MEVALONATE_PATHWAY,7,Up,0.802750186844095,0.958646599941354
691,WP_FOXA2_PATHWAY,9,Up,0.804286317192082,0.959091064205898
692,WP_PRION_DISEASE_PATHWAY,28,Down,0.805531280018675,0.959187535744781
693,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,78,Down,0.8078192367822,0.960523883273497
694,WP_ACUTE_MYELOID_LEUKEMIA,56,Down,0.809700085969318,0.961035682423615
695,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.8106711005757,0.961035682423615
696,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.811748586124801,0.961035682423615
697,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.813742851767756,0.961039037254303
698,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.814084038839203,0.961039037254303
699,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,31,Up,0.815508214715064,0.96134301706039
700,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.81709430845494,0.961596731839196
701,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.818057413858345,0.961596731839196
702,WP_CILIARY_LANDSCAPE,185,Down,0.819827159729487,0.962304244468799
703,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,19,Down,0.822072439550364,0.962361805567126
704,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.822212028057351,0.962361805567126
705,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Down,0.824588633955389,0.963774516849986
706,WP_ACUTE_VIRAL_MYOCARDITIS,67,Down,0.827358329352609,0.965281488987787
707,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Down,0.828220889216463,0.965281488987787
708,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Up,0.834117888938934,0.965337280778749
709,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.835846225592256,0.965337280778749
710,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.836041120124195,0.965337280778749
711,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.836308167487107,0.965337280778749
712,WP_PI3KAKT_SIGNALING,182,Up,0.83650103665256,0.965337280778749
713,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.837173270686343,0.965337280778749
714,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.83783960311323,0.965337280778749
715,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,64,Down,0.838084687917204,0.965337280778749
716,WP_CELLULAR_PROTEOSTASIS,6,Up,0.839859785978474,0.965337280778749
717,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.841171682225804,0.965337280778749
718,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.843594001398818,0.965337280778749
719,WP_HIPPOYAP_SIGNALING,16,Down,0.843816511941243,0.965337280778749
720,WP_WNT_SIGNALING_WP428,60,Down,0.846162710922437,0.965337280778749
721,WP_IL11_SIGNALING,40,Up,0.846876596272804,0.965337280778749
722,WP_HEART_DEVELOPMENT,17,Down,0.848470658228943,0.965337280778749
723,WP_PPARALPHA_PATHWAY,15,Up,0.85074867110072,0.965337280778749
724,WP_CCL18_SIGNALING,22,Up,0.852836482052667,0.965337280778749
725,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Up,0.8564299202201,0.965337280778749
726,WP_HISTONE_MODIFICATIONS,37,Down,0.856856812695332,0.965337280778749
727,WP_NUCLEOTIDE_GPCRS,7,Up,0.857477822374564,0.965337280778749
728,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,51,Down,0.8582169181171,0.965337280778749
729,WP_ANGIOGENESIS,15,Down,0.858696066161702,0.965337280778749
730,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,44,Down,0.858719503527519,0.965337280778749
731,WP_RAS_SIGNALING,119,Up,0.859304372201367,0.965337280778749
732,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Up,0.859517775410553,0.965337280778749
733,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.859735121204585,0.965337280778749
734,WP_BASE_EXCISION_REPAIR,29,Down,0.86068126330533,0.965337280778749
735,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.862205759869238,0.965337280778749
736,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.862243008074223,0.965337280778749
737,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.864571539980356,0.965639311994968
738,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.864856568267338,0.965639311994968
739,WP_IL5_SIGNALING,37,Down,0.869051073131306,0.96900958627902
740,WP_G_PROTEIN_SIGNALING,62,Up,0.870904946867247,0.969764427322448
741,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Down,0.87631272533745,0.972379147678965
742,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.877078380090875,0.972379147678965
743,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,18,Down,0.877476842598188,0.972379147678965
744,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,27,Up,0.877973405185862,0.972379147678965
745,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.881124623042811,0.973404593413904
746,WP_CELL_CYCLE,95,Up,0.882552268825143,0.973404593413904
747,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.884321384585589,0.973404593413904
748,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.885575464197523,0.973404593413904
749,WP_ALSTROM_SYNDROME,27,Down,0.886320087949575,0.973404593413904
750,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.886403016968862,0.973404593413904
751,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Up,0.887494825414398,0.973404593413904
752,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,277,Up,0.890558230674264,0.973404593413904
753,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,40,Up,0.892757493947054,0.973404593413904
754,WP_KREBS_CYCLE_DISORDERS,11,Down,0.893205690104384,0.973404593413904
755,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,18,Down,0.894144625014634,0.973404593413904
756,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Down,0.894298641773034,0.973404593413904
757,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.89639725401517,0.973404593413904
758,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.897987394444392,0.973404593413904
759,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.898342996152579,0.973404593413904
760,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.898498258671323,0.973404593413904
761,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.901522858016047,0.973404593413904
762,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.901698023409064,0.973404593413904
763,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,63,Down,0.903208771158878,0.973404593413904
764,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Down,0.903278710092781,0.973404593413904
765,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.903706934419462,0.973404593413904
766,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.907627880084118,0.973524718746618
767,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.910001939566803,0.973524718746618
768,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Up,0.910298051835102,0.973524718746618
769,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,0.912219122553298,0.973524718746618
770,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,49,Up,0.913234543147382,0.973524718746618
771,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.914427102558316,0.973524718746618
772,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.914834626857543,0.973524718746618
773,WP_NOTCH_SIGNALING_WP268,35,Down,0.915012282593962,0.973524718746618
774,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.916094528244692,0.973524718746618
775,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.916414585429085,0.973524718746618
776,WP_TYPE_II_INTERFERON_SIGNALING,30,Up,0.917563316838174,0.973524718746618
777,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Up,0.919162768838078,0.973524718746618
778,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.91917746503018,0.973524718746618
779,WP_PURINERGIC_SIGNALING,16,Down,0.92491260380659,0.975119878124293
780,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.925613754876031,0.975119878124293
781,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.92653755627031,0.975119878124293
782,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Down,0.927276343947592,0.975119878124293
783,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Up,0.927731887751509,0.975119878124293
784,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.927783961710492,0.975119878124293
785,WP_IL2_SIGNALING,37,Down,0.929248616458632,0.975145112057852
786,WP_PEPTIDE_GPCRS,16,Down,0.930174827763922,0.975145112057852
787,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.93911272287794,0.97895237716864
788,WP_CAMKK2_PATHWAY,30,Up,0.940136698433325,0.97895237716864
789,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.940346931433885,0.97895237716864
790,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.940458855938799,0.97895237716864
791,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Up,0.940683836643579,0.97895237716864
792,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.940934809123256,0.97895237716864
793,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Down,0.945422565390369,0.982381076773851
794,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.948125646396498,0.983949033539943
795,WP_PRIMARY_OVARIAN_INSUFFICIENCY,90,Up,0.95254451465657,0.98729142148052
796,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Up,0.955459394944205,0.988570742818069
797,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,24,Down,0.956178254885923,0.988570742818069
798,WP_VALPROIC_ACID_PATHWAY,9,Down,0.959206100952463,0.989456395914932
799,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.959436480990328,0.989456395914932
800,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.963230479178547,0.989843627316921
801,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,1,Down,0.963777298772855,0.989843627316921
802,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,11,Up,0.965045311428798,0.989843627316921
803,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.96529603422955,0.989843627316921
804,WP_INTEGRATED_CANCER_PATHWAY,40,Up,0.965818296556801,0.989843627316921
805,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.970684076881881,0.993594632733751
806,WP_OSTEOPONTIN_SIGNALING,12,Down,0.972077561507954,0.993786489680588
807,WP_CYTOSINE_METHYLATION,7,Up,0.97668464167914,0.994241272937216
808,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Up,0.977074664892432,0.994241272937216
809,WP_DNA_MISMATCH_REPAIR,21,Down,0.978249084159096,0.994241272937216
810,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.979976832195569,0.994241272937216
811,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,82,Up,0.980305217824787,0.994241272937216
812,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Down,0.982185272557094,0.994241272937216
813,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.983412488709968,0.994241272937216
814,WP_AEROBIC_GLYCOLYSIS,10,Up,0.983560115625454,0.994241272937216
815,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.983560115625454,0.994241272937216
816,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.984797554443064,0.994241272937216
817,WP_STEROID_BIOSYNTHESIS,2,Down,0.985795048531196,0.994241272937216
818,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.987387817693372,0.994630271123886
819,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.990011713271375,0.9950451877026
820,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Up,0.990214871257442,0.9950451877026
821,WP_VITAMIN_D_METABOLISM,6,Up,0.994178808883026,0.997456136210129
822,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.995035126170784,0.997456136210129
823,WP_VITAMIN_D_RECEPTOR_PATHWAY,87,Up,0.996691397717588,0.997902444373381
824,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Down,0.998891705071286,0.998891705071286
